Ulocuplumab April 13, 2017 Ulocuplumab Trade Name Orphan Indication Acute myeloid leukaemia EU Market Approval EU EU Designation Date 2015-02-12 00:00:00 Sponsor Bristol-Myers Squibb Pharma EEIG
